Literature DB >> 3051215

Controlling emesis in patients receiving cancer chemotherapy.

R J Gralla1, M G Kris, L B Tyson, R A Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3051215     DOI： 10.1007/978-3-642-82932-1_12

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  2 in total

Review 1.  Stratified administration of serotonin 5-HT3 receptor antagonists (setrons) for chemotherapy-induced emesis. Economic implications.

Authors:  L A Sanchez; M Holdsworth; S B Bartel
Journal:  Pharmacoeconomics       Date:  2000-12       Impact factor: 4.981

2.  Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.

Authors:  David Pérol; Jocelyne Provençal; Anne-Claire Hardy-Bessard; David Coeffic; Jean-Phillipe Jacquin; Cécile Agostini; Thomas Bachelot; Jean-Paul Guastalla; Xavier Pivot; Jean-Pierre Martin; Agathe Bajard; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2012-12-17       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.